Lortab Detox & Treatment in British Columbia
Lortab is a prescription pain medication used to relieve moderate to severe pain. The two primary ingredients in Lortab is hydrocodone and acetaminophen. The acetaminophen in the Lortab is there to enhance the pain-relieving effects of the hydrocodone. Lortab is similar to the drug combination branded as Vicodin and is another hydrocodone-based pain medication. This particular pain medication operates identical to other opioids-based drugs, and the hydrocodone binds to the opioid receptors in the brain and the nervous system. Hydrocodone based drugs have been approved for use in Canada since the 1950s and were primarily used to treat cough. However, the combination of hydrocodone and acetaminophen is a common pain medication prescribed in Canada to treat pain.
Throughout the province of British Columbia, there are countless people addicted to prescription opioids. Lortab is notorious for being addictive, like most hydrocodone pain medication. When Lortab is misused, the drug-user will develop both tolerance and dependence on the drug causing painful withdrawal symptoms. A dependency on opioids will escalate into an addiction where the addict is then trying to find new ways to get the drug or may start using heroin. Opioid addiction is difficult to treat because of the withdrawal pain, which does prevent many opioid addicts from getting the help they need. Hydrocodone withdrawal occurs when someone accustomed to using the drug stops taking it and experiences the withdrawal pain. Some of the withdrawal symptoms include anxiety, chills, insomnia, irritability, muscle aches and pain, and nausea and vomiting.
The withdrawal management services in British Columbia are delivered through five regional health authorities. There is also the First Nations Health Authority and the Provincial Health Services Authority. Within the province is both the publicly funded and private system of addiction treatment. There are dedicated inpatient and outpatient programs in the province that provide withdrawal management services. Typically, the withdrawal management programs in the province are located within the major urban areas. These are short-term programs providing medical support for the acute symptoms of withdrawal, such as what Lortab causes. Some of the programs are linked to residential treatment or transitional housing services.
According to the Canadian Center on Substance Use and Addiction (CCSA) in 2017, around 13% of the Canadian population are using opioid pain medication. Approximately 2% of these individuals reported using pain medication for non-medical reasons. Across the country and within the province, the rate of hospitalizations because of opioid misuse has been increasing. Many of the admissions are due to accidental overdose that is prevented before the person slips into a coma or dies. The 2017 Canadian Guide for Opioid Therapy and Chronic Non-Cancer Pain estimated that opioids are associated with a 5.5% risk of addiction. Most people who become addicted to opioids in Canada received a prescription to treat pain or discomfort. Long-term regular use and misuse of opioids cause tolerance, dependence, and then addiction.
As of 2019, from January to March in the province of British Columbia, there have been 299 opioid-related overdose deaths, which is a rate of 23.8 per 100,000 population. In 2016 within the province the total number of opioid-related deaths reached over 1,400. If you are struggling with an addiction Lortab or other hydrocodone-based drugs, it is essential to find treatment.